期刊
EMBO MOLECULAR MEDICINE
卷 3, 期 11, 页码 682-696出版社
WILEY-BLACKWELL
DOI: 10.1002/emmm.201100179
关键词
astrocyte; glial scar; GSK-3; migration; spinal cord injury
资金
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan
- MEXT
- Takeda Foundation
- JST-SORST
- Japan Society for Promotion of Science (JSPS)
- Keio University
- Naito Foundation
- Project for the Realization of Regenerative Medicine
- Grants-in-Aid for Scientific Research [23123516, 23650327, 22700342, 22390292, 22600011] Funding Source: KAKEN
The migratory response of astrocytes is essential for restricting inflammation and preserving tissue function after spinal cord injury (SCI), but the mechanisms involved are poorly understood. Here, we observed stimulation of in vitro astrocyte migration by the new potent glycogen synthase kinase-3 (GSK-3) inhibitor Ro3303544 and investigated the effect of Ro3303544 administration for 5 days following SCI in mice. This treatment resulted in accelerated migration of reactive astrocytes to sequester inflammatory cells that spared myelinated fibres and significantly promoted functional recovery. Moreover, the decreased extent of chondroitin sulphate proteoglycans and collagen IV demonstrated that scarring was reduced in Ro3303544-treated mice. A variety of in vitro and in vivo experiments further suggested that GSK-3 inhibition stimulated astrocyte migration by decreasing adhesive activity via reduced surface expression of beta 1-integrin. Our results reveal a novel benefit of GSK-3 inhibition for SCI and suggest that the stimulation of astrocyte migration is a feasible therapeutic strategy for traumatic injury in the central nervous system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据